Flow cytometric analysis of DMBA-induced early in vivo ras expression

In Vivo

Volumn 16, Issue 5, 2002, Pages 323-326

  Gyöngyi, Zoltán ^a   Grama, László ^a   Nádasi, Edit ^a   Sándor, János ^a   Németh, Árpád ^a   Varga, Csaba ^a   Kiss, István ^a   Ember, István ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Biomarker; DMBA; Flow cytometry; Gene expression; Long Evans rats; Ras

Indexed keywords

ANTIBODY; CARCINOGEN; DIMETHYLBENZ[A]ANTHRACENE; MESSENGER RNA; RAS PROTEIN; 7,12 DIMETHYLBENZ[A]ANTHRACENE; PROTEIN P21; TUMOR MARKER;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BREAST CANCER; CELL POPULATION; CHROMOSOME; CHROMOSOME ABERRATION; CODON; CONTROLLED STUDY; DATA BASE; DRUG EXPOSURE; FEMUR; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE MUTATION; IN VIVO STUDY; LEUKEMIA; LEUKEMOGENESIS; LIGHT SCATTERING; NONHUMAN; OUTBRED STRAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PUBLICATION; RAT; RAT STRAIN; TRISOMY; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EXPERIMENTAL LEUKEMIA; GENE EXPRESSION; GENETICS; LONG EVANS RAT; METABOLISM; ONCOGENE RAS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BONE MARROW CELLS; CARCINOGENS; FLOW CYTOMETRY; GENE EXPRESSION; GENES, RAS; LEUKEMIA, EXPERIMENTAL; ONCOGENE PROTEIN P21(RAS); RATS; RATS, LONG-EVANS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036762456     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ito Y, Ueda N, Maeda S, Murao S, Sugiyama T, Lee H and Harvey RG: Induction of chromosomal aberrations in rat bone marrow cells and mutation in Salmonella typhimurium by benz[a]anthracene derivatives. Mutat Res 206: 55-63, 1988.
2. Huggins CB, Yoshida H and Bird CC: Hormone-dependent stem-cell rat leukemia evoked by a series of feedings of 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 52(4): 1301-1305, 1974.
3. Huggins C, Grand L and Oka H: Hundred day leukemia: Preferential induction in rat by pulse-doses of 7,8,12-trimethylbenz[a]anthracene. J Exp Med 131: 321-330, 1970.
4. Huggins CB and Sugiyama T: Induction of leukemia in rat by pulse doses of 7,12-dimethylbenz[a]anthracene. Proc Natl Acad Sci 55: 74-81, 1966.
5. Kozma L, Kiss A, Ember I and Kertai P: Studies on acute myelomonocytic leukemia in LBF1 rats. Cancer Lett 68: 185-192, 1993.
6. Kurita Y, Sugiyama T and Nishizuka Y: Cytogenetic studies on rat leukemia induced by pulse doses of 7,12-dimethylbenz[a]anthracene. Cancer Res 28: 1738-1752, 1968.
7. Sugiyama T, Uenaka H, Ueda N, Fukuhara S and Maeda S: Reproducible chromosome changes of policyclic hydrocarbon-induced rat leukemia: Incidence and chromosome banding pattern. J Natl Cancer Inst 60(1): 153-160, 1978.
8. Osaka M, Matsuo S, Koh T and Sugiyama T: Specific N-ras mutation in bone marrow within 48 h of 7,12-dimethylbenz[a]anthracene treatment in Huggins-Sugiyama rat leukemogenesis. Mol Carcinog 16: 126-131, 1996.
9. Walentinsson A and Levan G: Ras gene mutations in 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat sarcomas. Cancer Lett 166(1): 47-53, 2001.
10. Chen HL, Maeda S, Takahashi R and Sugiyama T: Chromosome marker and enhanced expression of c-Ha-ras in a DMBA-induced erythroleukemia in cell line (D5A1). Cancer Genet Cytogenet 28: 301-309, 1987.
11. Gyongyi Z, Ember I, Kiss I and Varga CS: Changes in expression of onco- and suppressor genes in peripheral leukocytes - as potential biomarkers of chemical carcinogenesis. Anticancer Res 21: 3377-3380, 2002.
12. Shen WPV, Aldrich TH, Venta-Perez G, Franza BR and Furth ME: Expression of normal and mutant ras proteins in human acute leukemia. Oncogene 1(2): 157-165, 1987.
13. Scheele JS, Rapple D and Lubbert M: The role of Ras and other low molecular weight guanine nucleotide (GTP)-binding proteins during hematopoietic cell differentiation. Cell Mol Life Sci 57: 1950-1963, 2000.
14. Andreeff M, Slater DE, Bressler J and Furth ME: Cellular ras oncogene expression and cell cycle measured by flow cytometry in hematopoietic cell lines. Blood 67(3): 676-681, 1986.
15. Thorn J, Molloy P and Iland H: SSCP detection of N-ras promoter mutations in AML patients. Exp Hem 23: 1098-1103, 1995.
16. Liwo A, Gibson KD, Scheraga HA, Brandt-Rauf PW, Monaco R and Pincus MR: Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP. J Protein Chem 13(2): 237-251, 1994.
17. Osaka M, Matsuo S, Koh T and Sugiyama T: Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[a] anthracene-induced rat leukemia. Mol Carcinog 18: 206-212, 1997.
18. Seidel HJ: The effect of dimethylbenz[a]anthracene on murine hematopoiesis. Z Krebs 89: 221-229, 1977.
19. Kuliczkowski K, Darley RL, Jacobs A, Pauda RA and Hoy TG: Upregulation of p21 ras levels in HL-60 cells during differentiation induction with DMSO, all-trans-retinoid acid and TPA. Leuk Res 19(4): 291-296, 1995.
20. Ember I, Kiss I and Pusztai ZS: EFfect of 7,12-dimethylbenz[a]anthracene on onco/suppressor gene action in vivo: A short-term experiment. Anticancer Res 18: 445-448, 1998.
21. Perjesi P, Gyöngyi Z and Bayer Z: Effect of E-2-(4′-methoxy-benzylidene)-1-benzosuberone on the 7,12-dimethylbenz[a]anthracene-induced onco/suppressor gene action in vivo II: A 48-hour experiment. Anticancer Res 20(3): 1839-1848, 2000.